يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"Glucagon-Like Peptide-1 Receptor"', وقت الاستعلام: 0.90s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Efficacy and safety of semaglutide in patients with heart failure with preserved ejection fraction and obesity.

    المؤلفون: Rehman, Ayesha, Saidullah, Shahab, Asad, Muhammad, Gondal, Umer R., Ashraf, Amna, Khan, Muhammad F., Akhtar, Waheed, Mehmoodi, Amin, Malik, Jahanzeb

    المصدر: Clinical Cardiology; May2024, Vol. 47 Issue 5, p1-8, 8p

    مصطلحات موضوعية: HEART failure patients, VENTRICULAR ejection fraction, GLUCAGON-like peptide-1 receptor, PATIENT safety, WEIGHT loss, INTERMITTENT claudication

    النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Improved health‐related quality of life with semaglutide in people with non‐alcoholic steatohepatitis: A randomised trial.

    المؤلفون: Romero‐Gómez, Manuel, Armstrong, Matthew J., Funuyet‐Salas, Jesús, Mangla, Kamal Kant, Ladelund, Steen, Sejling, Anne‐Sophie, Shrestha, Ichhya, Sanyal, Arun J.

    المصدر: Alimentary Pharmacology & Therapeutics; Aug2023, Vol. 58 Issue 4, p395-403, 9p, 1 Chart, 2 Graphs, 1 Map

    مصطلحات موضوعية: NON-alcoholic fatty liver disease, QUALITY of life, GLUCAGON-like peptide-1 receptor, SEMAGLUTIDE, GLUCAGON-like peptide-1 agonists, LUTEINIZING hormone releasing hormone

    النص الكامل

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    The role of glia in the physiology and pharmacology of glucagon‐like peptide‐1: implications for obesity, diabetes, neurodegeneration and glaucoma.

    المؤلفون: Cui, Qi N.1 (AUTHOR), Stein, Lauren M.2 (AUTHOR), Fortin, Samantha M.2 (AUTHOR), Hayes, Matthew R.2 (AUTHOR) hayesmr@pennmedicine.upenn.edu

    المصدر: British Journal of Pharmacology. Feb2022, Vol. 179 Issue 4, p715-726. 12p. 2 Diagrams.

    مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *PHYSIOLOGY, *PHARMACOLOGY, *GLYCEMIC control, *GLAUCOMA, *GLUCAGON-like peptide-1 agonists

    النص الكامل

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Effects of switching from liraglutide to semaglutide or dulaglutide in patients with type 2 diabetes: A randomized controlled trial.

    المؤلفون: Takahiro Iijima, Makoto Shibuya, Yuzuru Ito, Yasuo Terauchi

    المصدر: Journal of Diabetes Investigation; Jun2023, Vol. 14 Issue 6, p774-781, 8p

    مصطلحات موضوعية: TYPE 2 diabetes, SEMAGLUTIDE, RANDOMIZED controlled trials, GLUCAGON-like peptide-1 receptor, LIRAGLUTIDE

    مصطلحات جغرافية: JAPAN

    النص الكامل

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Evaluating the usability and safety of the semaglutide single‐dose pen‐injectors through summative (human factors) usability testing.

    المؤلفون: Klonoff, David C1 (AUTHOR) dklonoff@diabetestechnology.org, Bassock, Stephanie2 (AUTHOR), Dwyer, Andrea3 (AUTHOR), Engels, Ella3 (AUTHOR), Qvist, Marianne4 (AUTHOR), Sparre, Thomas4 (AUTHOR), Snitker, Soren4 (AUTHOR)

    المصدر: Journal of Diabetes Investigation. Jun2021, Vol. 12 Issue 6, p978-987. 10p.

    مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *ADULTS, *MEDICAL personnel, *SUMMATIVE tests, *INJECTIONS, *SEMAGLUTIDE

    النص الكامل

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non‐alcoholic fatty liver disease assessed by magnetic resonance imaging.

    المؤلفون: Flint, Anne, Andersen, Grit, Hockings, Paul, Johansson, Lars, Morsing, Anni, Sundby Palle, Mads, Vogl, Thomas, Loomba, Rohit, Plum‐Mörschel, Leona

    المصدر: Alimentary Pharmacology & Therapeutics; Nov2021, Vol. 54 Issue 9, p1150-1161, 12p, 3 Charts, 3 Graphs

    مصطلحات موضوعية: NON-alcoholic fatty liver disease, MAGNETIC resonance imaging, SEMAGLUTIDE, GLUCAGON-like peptide-1 receptor, LIVER

    النص الكامل

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث